157 related articles for article (PubMed ID: 36916294)
1. High expression of centromere protein N as novel biomarkers for gastric adenocarcinoma.
Wang X; Zhang K; Fu C; Wu F; Zhang J; Han B; Pan H; Luan L
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1798. PubMed ID: 36916294
[TBL] [Abstract][Full Text] [Related]
2. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
[TBL] [Abstract][Full Text] [Related]
3. Short hairpin RNA-mediated down-regulation of CENP-A attenuates the aggressive phenotype of lung adenocarcinoma cells.
Wu Q; Chen YF; Fu J; You QH; Wang SM; Huang X; Feng XJ; Zhang SH
Cell Oncol (Dordr); 2014 Dec; 37(6):399-407. PubMed ID: 25228009
[TBL] [Abstract][Full Text] [Related]
4. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
[TBL] [Abstract][Full Text] [Related]
5. ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth.
Li Y; Zhu Z; Zhang S; Yu D; Yu H; Liu L; Cao X; Wang L; Gao H; Zhu M
PLoS One; 2011 Mar; 6(3):e17794. PubMed ID: 21423629
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
Wu X; Wang S; Wang C; Wu C; Zhao Z
Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
[TBL] [Abstract][Full Text] [Related]
7. HJURP inhibits proliferation of ovarian cancer cells by regulating CENP-A/CENP-N.
Zhang Y; Zhang W; Sun L; Yue Y; Shen D; Tian B; Du M; Dong M; Liu Y; Zhang D
Bull Cancer; 2022 Oct; 109(10):1007-1016. PubMed ID: 35940943
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between CENP-B gene expression and the cell cycle].
Zhang HX; Chen DG; Peng A; Wang YC
Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):291-8. PubMed ID: 8571711
[TBL] [Abstract][Full Text] [Related]
10. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
PeerJ; 2021; 9():e11342. PubMed ID: 33987018
[TBL] [Abstract][Full Text] [Related]
11. [Role of centromere protein H in human gastric cancer cell proliferation].
Quan T; He B; Liu T; Li W; Wu S; Jiang Q; Liu W; Liu H; Xu X
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):265-9. PubMed ID: 22381774
[TBL] [Abstract][Full Text] [Related]
12. Centromere protein A dynamics in human pluripotent stem cell self-renewal, differentiation and DNA damage.
Ambartsumyan G; Gill RK; Perez SD; Conway D; Vincent J; Dalal Y; Clark AT
Hum Mol Genet; 2010 Oct; 19(20):3970-82. PubMed ID: 20650959
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
14. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
15. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
Zha Z; Zhang P; Li D; Liu G; Lu L
Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
[TBL] [Abstract][Full Text] [Related]
16. Centromere protein N promotes lung adenocarcinoma progression by activating PI3K/AKT signaling pathway.
Zheng Y; You H; Duan J; Chen B; Wu C; Chen P; Wang M
Genes Genomics; 2022 Sep; 44(9):1039-1049. PubMed ID: 35150399
[TBL] [Abstract][Full Text] [Related]
17. FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration.
Yang Y; Gao Y; Liu XS; Huang ZM; Zhang Y; Zhang YH; Liu ZY; Chen YX; Pei ZJ
Exp Ther Med; 2024 Aug; 28(2):305. PubMed ID: 38873045
[TBL] [Abstract][Full Text] [Related]
18. The IRF2/CENP-N/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis.
Qi CL; Huang ML; Zou Y; Yang R; Jiang Y; Sheng JF; Kong YG; Tao ZZ; Feng HY; Hua QQ; Bu LH; Chen SM
J Exp Clin Cancer Res; 2021 Dec; 40(1):390. PubMed ID: 34893086
[TBL] [Abstract][Full Text] [Related]
19. MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis.
Luo WZ; Li X; Wu XX; Shang YW; Meng DH; Chen YL; Zhang QS
Int J Gen Med; 2023; 16():1681-1693. PubMed ID: 37181643
[TBL] [Abstract][Full Text] [Related]
20. Insulin Signaling Regulates the FoxM1/PLK1/CENP-A Pathway to Promote Adaptive Pancreatic β Cell Proliferation.
Shirakawa J; Fernandez M; Takatani T; El Ouaamari A; Jungtrakoon P; Okawa ER; Zhang W; Yi P; Doria A; Kulkarni RN
Cell Metab; 2017 Apr; 25(4):868-882.e5. PubMed ID: 28286049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
